Table 3. The relationship between SEZ6L2 expression and clinical features analyzed using a logistic regression model.
| Characteristics | Total (n) | Odds ratio (OR) | P |
|---|---|---|---|
| T stage (T3 & T4 vs. T1 & T2) | 508 | 1.441 (1.008–2.065) | 0.046 |
| N stage (N1 vs. N0) | 460 | 1.521 (1.053–2.200) | 0.026 |
| M stage (M1 vs. M0) | 295 | 0.460 (0.096–1.778) | 0.278 |
| Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II) | 508 | 1.881 (1.296–2.745) | <0.001 |
| Age (>45 vs. ≤45) | 510 | 1.189 (0.840–1.685) | 0.329 |
| Gender (male vs. female) | 510 | 1.294 (0.876–1.917) | 0.197 |
| Extrathyroidal extension (yes vs. no) | 492 | 1.462 (0.997–2.150) | 0.052 |